Successful treatment of checkpoint inhibitor-associated bullous pemphigoid with dupilumab in a patient with angiosarcoma

被引：3
|
作者：
Hansen, Inga [1 ,2 ]
Gebhardt, Christoffer [1 ]
Booken, Nina [1 ]
Schneider, Stefan W. [1 ]
机构：
[1] Univ klinikum Hamburg Eppendorf, Klin Poliklin Dermatol & Venerol, Hamburg, Germany
[2] Univ klinikum Hamburg Eppendorf, Klin Dermatol & Venerol, Martinistr 52, Hamburg, 20246, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2024年 / 22卷 / 04期
关键词：
D O I：
10.1111/ddg.15340
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：587 / 589
页数：3
相关论文
共 50 条
  • [1] DPP-4 Inhibitor-associated Bullous Pemphigoid in a Hemodialysis Patient
    Usami, Jun
    Takezawa, Yumiko
    INTERNAL MEDICINE, 2020, 59 (04) : 593 - 593
  • [2] Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoid
    Gandarillas, Sophia
    Berger, Adam
    Stephenson, Ryan
    Mehregan, Darius
    Dasgeb, Bahar
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [3] Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
    Tasanen, Kaisa
    Varpuluoma, Outi
    Nishie, Wataru
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [4] Atypical clinical manifestation and protracted latency are observed in the emerging variant of checkpoint inhibitor-associated bullous pemphigoid
    Kridin, Khalaf
    Hammers, Christoph M.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (06) : 843 - 844
  • [5] Successful reintroduction and continuation of nivolumab in a patient with immune checkpoint inhibitor-induced bullous pemphigoid
    Mihailescu, Maria L.
    Brockstein, Bruce E.
    Desai, Nisha
    Waldinger, Jason
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2020, 2
  • [6] Successful Treatment of Psoriasis Combined with Bullous Pemphigoid with Dupilumab: A Case Report
    Liu, Jing-Hua
    Gao, Qian
    Ma, Wen-Yi
    Cheng, Zi-Lin
    Luo, Na-Na
    Hao, Ping-Sheng
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 1583 - 1587
  • [7] The Successful Treatment of COVID-19-Induced Bullous Pemphigoid With Dupilumab
    Savoldy, Michelle A.
    Tadicherla, Teja
    Moureiden, Zade
    Ayoubi, Noura
    Baldwin, Brooke T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [8] Successful treatment of eczema-like bullous pemphigoid and typical bullous pemphigoid with dupilumab: two case reports
    Xu, Yanqin
    Song, Weicheng
    Cai, Yan
    Huang, Rong
    Wei, Junxiao
    Liu, Hui
    Peng, Xiaoming
    Zeng, Kang
    Li, Changxing
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (03) : E144 - E146
  • [9] Regulatory T cell subsets in bullous pemphigoid and dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid
    Muramatsu, Ken
    Zheng, Miao
    Yoshimoto, Norihiro
    Ito, Takamasa
    Ujiie, Inkin
    Iwata, Hiroaki
    Shimizu, Hiroshi
    Ujiie, Hideyuki
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2020, 100 (01) : 23 - 30
  • [10] Exacerbation of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid by the immune checkpoint inhibitors durvalumab and tremelimumab
    Inoue, Shinichiro
    Mai, Yosuke
    Youh, Joohyung
    Shimano, Mayuna
    Hikichi, Shiori
    Kosumi, Hideyuki
    Ujiie, Inkin
    Izumi, Kentaro
    Usami, Makoto
    Ujiie, Hideyuki
    JOURNAL OF DERMATOLOGY, 2025,
12345